Belgian market runs out of diabetes drug Ozempic


Ozempic, the diabetic drug also used to lose weight, will no longer be available in Belgium in the coming weeks and months. The manufacturer has informed all doctors of this, writes Het Laatste Nieuws on Thursday.

Ozempic is a drug launched in 2017 by Danish pharmaceutical company Novo Nordisk for patients with type 2 diabetes. The drug's active ingredient, semaglutide, lowers blood glucose levels and also reduces the risk of the disease's side effects, such as poorly healing wounds, kidney problems and blindness.

Global demand for the drug is so high that production cannot keep up as people increasingly use it to lose weight. The strongest dose is no longer available until the end of December, while other doses are temporarily in short supply.

"We are doing everything we can to ramp up production," says Novo Nordisk. "We work 24 hours a day, seven days a week." In the meantime, doctors should look for alternatives for diabetes patients, the company says.

A few weeks ago, the Federal Agency for Medicines and Health Products (FAGG) called on doctors and pharmacists to reserve Ozempic for patients with diabetes. Ozempic has been on restricted availability for over a year and will remain so until at least the beginning of 2024.

Rybelsus, the pill alternative, is also currently unavailable. Inappropriate use should be restricted, especially in patients with a BMI below 30. The FAMHP is monitoring the situation at both national and European levels.



Related News

Website preview
Novo Nordisk is testing Ozempic in children aged 6 to 12 as weight loss treatment
Danish pharmaceutical company Novo Nordisk is studying whether semaglutide, the active ingredient in Ozempic, can be used in children aged six to 12, writes De Tijd.
Website preview
Use of diabetes drug against obesity threatens shortage in Belgian supplies
Doctors in Belgium are being urged to stop prescribing Ozempic - which regulates blood sugar levels - to people without diabetes, as there is an imminent shortage due to the drug being used for weight loss.



Get updates in your mailbox

By clicking "Subscribe" I confirm I have read and agree to the Privacy Policy.


Belga News Agency delivers dependable, rapid and high-quality information 24 hours a day, 7 days a week, from Belgium and abroad to all Belgian media. The information covers all sectors, from politics, economics and finance to social affairs, sports and culture, not to mention entertainment and lifestyle.

Every day, our journalists and press photographers produce hundreds of photos and news stories, dozens of online information items, plus audio and video bulletins, all in both national languages. Since the end of March 2022 English has been added as a language.

For public institutions, businesses and various organisations that need reliable information, Belga News Agency also offers a comprehensive range of corporate services to meet all their communication needs.


Arduinkaai 29 1000 Brussels